4039-18-3 Usage
Uses
Used in Organic Synthesis:
3,5-Diiodobenzamide is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions. Its unique structure allows it to participate in a range of processes, making it a versatile component in the creation of new compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3,5-diiodobenzamide serves as a key intermediate for the synthesis of new drugs. Its properties contribute to the development of innovative medications, potentially leading to breakthroughs in treatment options for various health conditions.
Used as a Research Compound:
3,5-Diiodobenzamide is also utilized in research settings to explore its properties and potential applications further. Its high purity and stability make it an ideal candidate for scientific studies, contributing to the advancement of knowledge in the field of chemistry and related disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 4039-18-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,3 and 9 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4039-18:
(6*4)+(5*0)+(4*3)+(3*9)+(2*1)+(1*8)=73
73 % 10 = 3
So 4039-18-3 is a valid CAS Registry Number.
4039-18-3Relevant academic research and scientific papers
IODINE(III)-MEDIATED RADIOFLUORINATION
-
, (2015/09/28)
A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18F is described. Processes, intermediates, reagents and radiolabelled compounds are described.
Potent mGluR5 antagonists: Pyridyl and thiazolyl-ethynyl-3,5-disubstituted- phenyl series
Alagille, David,Dacosta, Herve,Chen, Yelin,Hemstapat, Kamondanai,Rodriguez, Alice,Baldwin, Ronald M.,Conn, Jeffrey P.,Tamagnan, Gilles D.
supporting information; experimental part, p. 3243 - 3247 (2011/07/07)
We report the synthesis of four series of 3,5-disubstituted-phenyl ligands targeting the metabotropic glutamate receptor subtype 5: (2-methylthiazol-4-yl) ethynyl (1a-j,), (6-methylpyridin-2-yl)ethynyl (2a-j), (5-methylpyridin-2-yl) ethynyl (3a-j,), and (pyridin-2-yl)ethynyl (4a-j,). The compounds were evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro assay. All compounds were found to be full antagonists and exhibited low nanomolar to subnanomolar activity.
